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ABSTRACT Natural killer (NK) cells respond rapidly as a ﬁrst line of defense against
infectious pathogens. In addition, NK cells may provide a “rheostat” function and
have been shown to reduce the magnitude of antigen-speciﬁc T cell responses fol-
lowing infection to avoid immunopathology. However, it remains unknown whether
NK cells similarly modulate vaccine-elicited T cell responses following virus chal-
lenge. We used the lymphocytic choriomeningitis virus (LCMV) clone 13 infection
model to address whether NK cells regulate T cell responses in adenovirus vector-
vaccinated mice following challenge. As expected, NK cell depletion in unvaccinated
mice resulted in increased virus-speciﬁc CD4 and CD8 T cell responses and immu-
nopathology following LCMV challenge. In contrast, NK cell depletion had minimal
to no impact on antigen-speciﬁc T cell responses in mice that were vaccinated with
an adenovirus serotype 5 (Ad5)-GP vector prior to LCMV challenge. Moreover, NK
cell depletion in vaccinated mice prior to challenge did not result in immunopathol-
ogy and did not compromise protective efﬁcacy. These data suggest that adenovirus
vaccine-elicited T cells may be less sensitive to NK cell rheostat regulation than T
cells primed by LCMV infection.
IMPORTANCE Recent data have shown that NK cell depletion leads to enhanced
virus-elicited T cell responses that can result in severe immunopathology following
LCMV infection in mice. In this study, we observed that NK cells exerted minimal to
no impact on vaccine-elicited T cells following LCMV challenge, suggesting that ade-
novirus vaccine-elicited T cells may be less subject to NK cell regulation. These data
contribute to our understanding of NK cell regulatory functions and T cell-based
vaccines.
KEYWORDS NK cells, adenoviruses, lymphocytic choriomeningitis virus, vaccines
Natural killer (NK) cells are components of the innate immune system and playcritical roles in defense against many pathogens (1). NK cells express receptors that
are able to sense cellular stress and inﬂammatory cytokines (2). As immune modulators,
NK cells provide a “rheostat” function and can help promote or curtail adaptive cellular
immune responses (3–9). They can interact with antigen-presenting cells or T cells to
direct adaptive immune response (10). NK cells have been shown to modulate the
development of T cell responses to lymphocytic choriomeningitis virus (LCMV) infec-
tion, resulting in decreased CD4 and CD8 T cell responses that can reduce the risk
of immunopathology (3, 11). However, it is unknown whether NK cells provide a similar
rheostat function and regulate vaccine-elicited T cell responses.
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LCMV in mice is a well-described model to study immune responses in both acute
and chronic infection. A high dose of LCMV strain clone 13 (Cl-13) has been shown to
lead to persistent systemic infection, which has been reported to result from rapid viral
replication and T cell exhaustion (12). NK cells suppress T cell responses to LCMV
through the perforin-mediated elimination of activated T cells, but they do not directly
control viral replication (3–7, 11, 13–15). Depending on the infecting LCMV Cl-13 dose,
the absence of NK cell-mediated rheostat regulation of T cells can result in either an
enhanced functional T cell response that effectively clears the virus or, alternatively, an
overwhelming functional T cell response that leads to immunopathology (3, 5, 7, 11).
In addition to the context of infection, NK cells have been shown to play a role in
regulating the development of T cell responses following immunization (9, 16, 17). NK
cells have also been recently described as having memory potential (18–20). These
functions of NK cells warrant interest in understanding their role and potential to
augment vaccine-elicited immune responses. Currently, it remains unclear whether NK
cells exert a similar rheostat function on vaccine-elicited T cells following LCMV
challenge. Here we use adenovirus (Ad) vector-based vaccines due to their ability to
elicit robust T cell responses and because they have been shown to protect against
LCMV infection (21).
In this study, we compared the abilities of NK cells to regulate T cell responses
following LCMV Cl-13 infection in Ad5-GP-vaccinated and unvaccinated mice. We show
that NK cell depletion markedly impacted CD4 and CD8 T cell responses in unvac-
cinated animals but had minimal effects on T cell responses in vaccinated animals
following LCMV Cl-13 challenge. Moreover, high frequencies of vaccine-elicited T cell
responses did not lead to immunopathology following NK cell depletion. These data
suggest that adenovirus vaccine-elicited T cells are relatively insensitive to the NK cell
rheostat function and remain protective rather than immunopathological in the ab-
sence of NK cells.
RESULTS
NK cell depletion has a minimal impact on CD8 and CD4 T cell responses
elicited by Ad5-GP.We ﬁrst evaluated whether NK cells might exert a rheostat role and
suppress vaccine-elicited T cell responses following immunization. Mice received 500
g of anti-NK1.1 or an isotype control antibody on two consecutive days and were
subsequently immunized with 1  1010 viral particles (vp) of Ad5-GP (Fig. 1A). Ad5-GP
is a replication-incompetent adenovirus serotype 5 vector expressing a transgene for
GP, which is the envelope protein of LCMV. We assessed the kinetics, phenotype, and
frequency of GP33-speciﬁc CD8 T cell responses, and we observed that NK cell
depletion had a minimal impact on the development of CD8 T cells, as measured by
Db/GP33 tetramer binding assays following immunization (Fig. 1B). NK cell depletion
also did not appear to impact the development of terminal effector (KLRG1hi CD127lo)
or memory precursor (KLRG1lo CD127hi) CD8 T cells (Fig. 1C) but had a transient effect
on PD-1 expression (P  0.0079) (Fig. 1D). Similarly, NK cell depletion showed little
effect on the magnitude and frequency of the immunodominant GP33- or GP276-
speciﬁc CD8 interferon gamma-positive (IFN-) T cell responses (Fig. 1E) and GP61-
speciﬁc CD4 T cell responses, as measured by intracellular cytokine staining (Fig. 1F)
in tissues at week 8 postvaccination. These data suggest that NK cell depletion may
have less of an impact on T cell responses induced by Ad vector vaccination than on
those induced by viral infection (22).
NK cell modulation of CD8 and CD4 T cell responses in vaccinated versus
unvaccinated mice following LCMV challenge. To address whether vaccine-elicited
memory T cells are susceptible to NK cell rheostat regulation following LCMV challenge,
we depleted NK cells from both Ad5-GP-vaccinated and unvaccinated animals prior to
challenge with 2  106 PFU of LCMV Cl-13. We chose this dose of LCMV Cl-13 to
establish a chronic infection given its ability to serve as a model of immune pathology
with heightened T cell responses. We then evaluated the NK cell phenotype as well as
the magnitudes and frequencies of antigen-speciﬁc CD4 and CD8 T cells (Fig. 2A).
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FIG 1 NK cell depletion has a minimal impact on CD4 and CD8 T cell responses elicited by Ad5-GP. Naive C57BL/6 mice received
500 g of anti-NK1.1 or isotype control antibody prior to immunization with Ad5-GP. (A) Schematic of the experimental setup. (B)
(Continued on next page)
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We observed that more NK cells were activated in unvaccinated animals, as marked by
CD69 expression, with an increased upregulation of markers associated with activation
(NKG2D) and inhibitory (2B4) activities (Fig. 2B) (3, 7). On day 5 postinfection, unvac-
cinated NK cell-depleted mice exhibited markedly higher GP33-speciﬁc (P  0.0001 for
percent frequency and P  0.0035 for total numbers) and GP276-speciﬁc (P  0.0001
for percent frequency and P 0.0036 for total number) CD8 T cell responses than did
unvaccinated, isotype-treated mice, consistent with previous ﬁndings (Fig. 2C) (3, 5, 7,
11). In contrast, NK cell depletion had minimal to no impact on GP33- and GP276-
speciﬁc CD8 T cells in Ad5-GP-vaccinated mice following LCMV challenge (Fig. 2C).
Moreover, the depletion of NK cells using the asialo-GM1 antibody recapitulated these
results (data not shown).
NP396-speciﬁc CD8 T cell responses in vaccinated mice are de novo responses
induced by LCMV infection, as NP was not contained in the vaccine. NK cell depletion
FIG 1 Legend (Continued)
GP33-speciﬁc CD8 T cell responses measured via Db/AL11 tetramer binding assays. (C) Phenotypic differentiation of GP33-speciﬁc
CD8 T cells. (D) PD-1 (mean ﬂuorescence intensity [MFI]) expression on GP33 tetramer-positive CD8 T cells. (E) Intracellular
cytokine staining of GP33- and GP276-speciﬁc CD8 T cells. (F) Intracellular cytokine staining of GP61-speciﬁc CD4 T cells. Error
bars represent standard errors of the means for 5 mice per group with 1 sham-vaccinated control. Statistically signiﬁcant values are
indicated (**, P  0.01 by a Mann-Whitney U test).
FIG 2 NK cell modulation of T cell responses in vaccinated and unvaccinated mice following LCMV Cl-13 challenge. (A) Schematic outlining the experimental
setup. (B) Vaccinated and unvaccinated mice were challenged with LCMV Cl-13. At day 3 following infection, animals were sacriﬁced, and NK cell responses in
blood, spleen, and lymph node were evaluated as the percentage of activated NK cells, as marked by the upregulation of CD69, NKG2D expression on NK cells,
and 2B4 expression on NK cells. Error bars represent standard errors of the means for 5 ﬁve mice per group. Statistically signiﬁcant values are indicated (bold
line, P  0.01 [determined by a Mann-Whitney U test]). (C and D) Vaccinated or unvaccinated C57BL/6 mice received anti-NK1.1 or isotype control antibody
prior to infection with LCMV Cl-13. Animals were sacriﬁced at day 5 postinfection, and GP33 and GP276 (C) and NP396 (D) CD8 T cell responses in the spleen
were evaluated by intracellular cytokine staining. (E and F) GP61 CD4 T cell responses in the spleen were evaluated by intracellular cytokine staining. Error
bars represent standard errors of the means for 10 mice per group with 2 naive controls. Statistically signiﬁcant values are indicated (**, P 0.01; ***, P 0.005;
****, P  0.0001 [by a Mann-Whitney U test]).
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also increased NP396-speciﬁc CD8 T cell responses (P  0.0001 for percent frequency
and P  0.0003 for total numbers) (Fig. 2D) and GP61-speciﬁc CD4 T cell responses
(P  0.0001 for percent frequency and P  0.0035 for total numbers) in unvaccinated
animals (Fig. 2E and F). In contrast, NK cell depletion did not detectably impact the
generation of NP396- and GP61-speciﬁc responses in vaccinated mice. These data
suggest that NK cells have a far more limited role in modulating vaccine-primed and de
novo T cell responses in vaccinated mice than in unvaccinated mice following LCMV
Cl-13 challenge.
Vaccination prevents immunopathology associated with NK cell depletion
following LCMV Cl-13 challenge. Previous studies have shown that NK cell depletion
of naive mice prior to LCMV Cl-13 challenge led to higher magnitudes of CD4 and
CD8 T cell responses with increased functionality, contributing to immunopathology
(3, 11). We sought to evaluate if NK cell depletion would similarly lead to immunopa-
thology in vaccinated animals following LCMV Cl-13 challenge. We vaccinated C57BL/6
mice with 1  1010 vp of Ad5-GP, and after 45 days, we depleted NK cells by the
administration of 500 g of anti-NK1.1 or an isotype control antibody on day 2 and
day 1 prior to challenge. Following challenge with LCMV Cl-13, we observed that NK
cell depletion in vaccinated animals led to minimal differences in weight loss and
mortality (Fig. 3A and B). In contrast, NK cell depletion in unvaccinated animals led to
increased weight loss and mortality, as expected for unvaccinated animals (P  0.005)
(Fig. 3A and B). Viral plaque assays showed the clearance of viremia in vaccinated mice
by day 8, which was slightly accelerated by NK cell depletion (Fig. 3C). In contrast, NK
cell depletion did not impact viral loads in unvaccinated mice. Moreover, the immu-
nopathology induced by NK cell depletion in unvaccinated mice was abrogated by the
depletion of CD8 T cells (Fig. 3D) but not by the depletion of CD4 T cells (data not
shown), conﬁrming that immunopathology in unvaccinated mice was largely mediated
by CD8 T cells.
We then evaluated the pathological effects that could arise following NK cell
depletion. Vaccinated animals showed minimal evidence of hepatic pathology follow-
ing LCMV infection, regardless of NK cell depletion (Fig. 4A). In contrast, on day 7
post-LCMV Cl-13 challenge, liver pathology in unvaccinated animals was exacerbated
by NK cell depletion, with more-severe periportal and hepatic inﬁltrates of T lympho-
cytes associated with hepatocellular degeneration and vasculitis (Fig. 4B and C). Taken
together, these data indicate that Ad5-GP vaccination led to virus clearance and
prevented the development of immunopathology associated with unregulated virus-
elicited T cell responses following NK cell depletion.
CD8 T cells have distinct transcriptomic signatures as a function of vaccina-
tion and NK cell depletion. To understand why a higher CD8 T cell response in
vaccinated animals was protective whereas an increased CD8 T cell response in
unvaccinated animals was immunopathological following NK cell depletion, we com-
pared the transcriptomic proﬁles of GP33-speciﬁc CD8 T cells from vaccinated and
unvaccinated mice with and without NK cell depletion to understand the effect of prior
vaccination on the transcriptomic signature. We focused on GP33-speciﬁc CD8 T cells
since GP33 is the immunodominant CD8 T cell epitope elicited by Ad5-GP immuni-
zation (12). We sorted splenic GP33-speciﬁc CD8 T cells for microarray analysis at day
8 postinfection, which we chose as a time point prior to immunopathology in unvac-
cinated, NK cell-depleted animals (Fig. 5A). Unsupervised differential gene expression
analysis showed that major transcriptomic differences were observed between
GP33-speciﬁc CD8 T cells from vaccinated and unvaccinated animals. Smaller
numbers of genes were modulated following NK cell depletion within each treat-
ment group (Fig. 5B).
A comparison of the transcriptomic proﬁles of vaccinated mice to those of unvac-
cinated mice without NK cell depletion using gene set enrichment analysis (GSEA)
revealed that vaccinated animals showed an enhanced expression of pathways related
to T cell activation (normalized enrichment score [NES]  1.56; false discovery rate
[FDR]  0.08), nuclear factor of activated T cells (NFAT) signaling (NES  1.51; FDR 
Ad Vector Vaccination Impacts NK Cell Regulation Journal of Virology
June 2018 Volume 92 Issue 11 e02103-17 jvi.asm.org 5
FIG 3 Vaccination prevents immunopathology associated with NK cell depletion following LCMV Cl-13 challenge. Naive or
Ad5-GP-vaccinated C57BL/6 mice received 500 g anti-NK1.1 or isotype control antibody prior to infection with LCMV Cl-13.
(Continued on next page)
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0.10), and T cell anergy (NES  1.66; FDR  0.04) (Fig. 5C; see also Table S1 in the
supplemental material). These pathways likely reﬂect the T cell recall responses in
Ad5-GP-vaccinated animals. NFAT signaling and T cell anergy were previously de-
scribed as a phenotype of Ad5 vaccine-elicited CD8 T cells (23). Conversely, vaccinated
animals demonstrated decreased expression levels of interferon and antiviral re-
sponses, including type I interferon (NES  1.96; FDR  0.0076), interferon gamma
signaling (NES  2.19; FDR  0.00074), and inﬂammatory response (NES  1.35;
FDR  0.18) pathways. Genes associated with anti-inﬂammatory responses were also
enriched (Fig. 5D). Survival- and cell division-related pathways were downregulated,
such as MYC signaling (NES  1.56; FDR  0.09), the cell cycle (NES  1.95; FDR 
0.007), and BCL2 targets (NES  1.50; FDR  0.10), while positive regulation of
autophagy (NES 1.87; FDR 0.0072) was upregulated (Fig. 5C). Taken together, these
ﬁndings may reﬂect less inﬂammation due to the lower levels of LCMV replication and
subsequently the beginning of the T cell contraction phase in vaccinated animals (24).
We next compared transcriptomic proﬁles of GP33-speciﬁc CD8 T cells from
unvaccinated animals with and without NK depletion to investigate the impact of NK
cell depletion on the development of immunopathological CD8 T cells. Virus-elicited
FIG 3 Legend (Continued)
(A) Body weights were evaluated daily. (B) Survival of animals following LCMV Cl-13 challenge. (C) LCMV titers in serum as
measured by a plaque assay. (D) Weight loss and survival in unvaccinated animals following depletion of NK cells, CD8 T
cells, or both. Error bars represent standard errors of the means for 5 to 15 mice per group with 1 to 3 naive controls. B
represents baseline body weight. ND, not detectable. The dotted line represents weight loss euthanasia criteria. Statistically
signiﬁcant values (P  0.005 by a Mantel-Cox test) are indicated by arrows.
FIG 4 Prior vaccination prevents NK cell-mediated augmentation of pathology. Vaccinated and unvaccinated mice
were given anti-NK1.1 or isotype control antibody and then subsequently challenged with 2  106 PFU of LCMV
Cl-13. Animals were sacriﬁced at day 7 postchallenge for histopathology. (A) H&E staining of liver sections
(magniﬁcation, 20). (B) Example of hepatic pathology in an unvaccinated, NK cell-depleted animal, with hepatic
lipidosis and loss of nuclear detail consistent with hepatocyte degeneration (asterisk), vasculitis (arrow), and
lymphocytic inﬁltrates (arrowhead). (C) Scoring of hepatic pathology. Error bars represent standard errors of the
means for 2 to 3 mice per group with 1 naive control.
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FIG 5 Transcriptomic analysis of CD8 T cells from vaccinated and unvaccinated mice following LCMV Cl-13 challenge. (A) Schematic outlining the experimental
setup. (B) Heat map at day 8 following challenge showing the log2 expression levels of each gene transformed to a Z-score, where the average expression level
of each gene was subtracted and divided by its standard deviation across all samples, using a LIMMA F test (P  0.05) accounting for all genes differentially
expressed in at least one contrast. (C) Heat map representation of the GSEA-normalized enrichment scores of selected pathways with increased or decreased
expression levels in vaccinated versus unvaccinated animals (nominal P value of 0.05 and FDR of 0.20). Pathways that show increased or decreased
expression levels in vaccinated animals compared to unvaccinated animals following treatment with an isotype control antibody are indicated. IL-2,
(Continued on next page)
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GP33-speciﬁc CD8 T cells in NK cell-depleted unvaccinated mice demonstrated a
downregulation of pathways associated with T cell exhaustion (NES  1.66; FDR 
0.04), T lymphocyte anergy (NES  1.98; FDR  0.001), and NFATΔAP1 exhaustion-
anergy (NES  2.3; FDR  109), compared to undepleted mice (Fig. 6A and Table
S2). These pathways may be related via NFAT signaling (25). In complement to the
downregulation of exhaustion pathways, we observed decreased expression levels of
the inhibitory receptors PD-1 (Pdcd1 gene) (log2 fold change [FC]  1.02; P  0.04),
Tim-3 (Havrc2,) (log2 FC  0.95; P  0.01), 2B4 (CD244) (log2 FC  1.87; P  0.004),
and CD160 (CD160) (log2 FC  0.94; P  0.04) and the CTLA-4 signaling pathway
(NES  1.65; FDR  0.04) (Fig. 6A and B) (26). PD-1 expression was similarly
downregulated on GP33-speciﬁc CD8 T cells following NK cell depletion by ﬂow
cytometry (Fig. 6C). We also observed decreased expression levels of apoptosis (NES 
1.68; FDR  0.03) and cell death receptor activity (NES  1.54; FDR  0.08)
pathways. Inﬂammasome receptor and signaling (NES1.40; FDR 0.13), interferon
response (NES  1.48; FDR  0.10), and interferon gamma response (NES  1.56;
FDR  0.07) pathways were also downregulated. Furthermore, numerous pathways
associated with chromatin remodeling and organization, such as EZH2 signaling (NES
2.41; FDR  109), chromosome organization (NES  1.79; FDR  0.01), chromatin
assembly or disassembly (NES  1.75; FDR  0.007), histone deacetylase 3 (HDAC3)
targets (NES  1.77; FDR  0.02), and HDAC1 targets (NES  1.40; FDR  0.12),
were also downregulated in unvaccinated mice following NK cell depletion. However,
several chromatin-remodeling markers, including HDAC2 targets (NES  1.26; FDR 
0.09), were upregulated (Fig. 6A). Epigenetic modiﬁcation has been described for T cell
differentiation and exhaustion, and thus, these processes likely reﬂect distinct epige-
netic changes in their response to infection (27, 28). We then compared the transcrip-
tomic proﬁles of vaccinated and unvaccinated animals following NK cell depletion, and
we observed that CD8 T cells from vaccinated animals had a greater enrichment of
genes related to the activation as well as the upregulation of pathways related to
exhaustion than did unvaccinated animals (Fig. 6D and Table S3). Together, these data
support a model suggesting that NK cells further contribute to the suppression of T cell
responses in unvaccinated animals, possibly through promoting the upregulation of
inhibitory receptors and the development of a dysfunctional phenotype in virus-elicited
T cells (3, 5, 7, 11).
We further analyzed the effect of NK cell depletion on vaccine-elicited CD8 T cells
following LCMV Cl-13 challenge. We observed minimal differences in transcriptomic
proﬁles between vaccinated mice with and those without NK cell depletion, unlike for
unvaccinated animals (data not shown). Combined with the above-described immu-
nologic data, these ﬁndings suggest that vaccine-elicited T cells are less susceptible to
NK cell-mediated regulation.
DISCUSSION
NK cells can behave as immune modulators and can interact with many immune cell
populations, such as dendritic cells and T cells (10, 29, 30). While they can contribute
to promoting immune responses, NK cells have also been described as a rheostat that
downregulates T cell responses and thus reduces immunopathology following infec-
tion (3, 11). In our studies, we show that the rheostat role of NK cells is markedly small
for Ad5-GP vaccine-elicited T cells in mice following LCMV Cl-13 challenge. Consistent
with data from previous reports, we show that NK cells from unvaccinated animals
negatively regulated T cell responses following LCMV Cl-13 infection (3, 5, 7, 11).
However, CD4 and CD8 T responses in vaccinated mice were not detectably im-
FIG 5 Legend (Continued)
interleukin-2; TLR, Toll-like receptor; IFR7, interferon regulatory factor 7; TGF, transforming growth factor; TNF, tumor necrosis factor; IGF1, insulin-like growth
factor 1; PLK1, polo-like kinase 1; EGR, early growth response. (D) Gene interaction networks showing the leading genes with increased or decreased expression
levels in vaccinated versus unvaccinated isotype control-treated animals. Networks were generated by using the Cytoscape DyNet plug-in, and interactions were
inferred from GeneMania (four mice per group).
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FIG 6 Transcriptomic analysis of CD8 T cells from unvaccinated mice with or without NK cell depletion following LCMV Cl-13 challenge. (A) Heat map
representation of the GSEA-normalized enrichment scores of selected pathways with increased or decreased expression levels in NK cell-depleted animals
compared to isotype control-treated animals at day 8 postchallenge (four mice per group). PI3K, phosphatidylinositol 3-kinase; CTLA-4, cytotoxic-T lymphocyte-
associated antigen 4. (B) Gene interaction networks showing the leading genes with increased and decreased expression levels in unvaccinated animals
(Continued on next page)
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pacted by NK cell depletion following LCMV Cl-13 challenge. Moreover, CD8 T cells
were transcriptionally different in vaccinated versus unvaccinated mice following LCMV
infection and NK cell depletion, which likely contributed to their protective versus
immunopathological roles, respectively.
NK cell regulation appears to result in divergent outcomes depending upon the
infecting dose, the time of NK cell depletion, and the strain of LCMV used (3, 5, 7, 11).
We utilized an LCMV Cl-13 model of chronic infection to elucidate the role of NK cells
in modulating immunopathology. Unvaccinated mice exhibited immunopathology and
worse outcomes following NK depletion, as previously reported (3, 11). Our use of more
stringent criteria to monitor adverse effects may have contributed to the reduced
survival rates that we observed in the present studies compared with previous studies
(3, 5, 7, 11). An additional caveat is that NK1.1 is expressed on other cell populations
besides NK cells, although it has been shown that the rheostat role is probably not
mediated by NKT or  T cells in the context of LCMV infection (3). Moreover, depletion
with the asialo-GM1 antibody recapitulated the data obtained with anti-NK1.1.
Previous studies demonstrated that the NK cell-mediated negative regulation of
virus-elicited CD4 and CD8 T cell responses following LCMV infection is perforin
mediated (3, 7). Here we show that Ad5-GP vaccine-elicited memory CD4 and CD8
T cells are largely not susceptible to NK cell-mediated regulation following LCMV
challenge. We also did not observe major transcriptomic changes in vaccinated animals
following NK cell depletion. This suggests that responding Ad vector vaccine-elicited
CD8 T cells may not be phenotypically augmented following NK cell depletion when
they are challenged with LCMV.
We observed that LCMV Cl-13 challenge stimulated NK cell activation in both
unvaccinated and vaccinated animals. Multiple NK-T cell cross talk pathways, which can
result in either being targeted by NK cells or in protection against NK cell-mediated
destruction, have been previously described in the literature. The net balance of
activating and inhibitory signals determines NK cell activation and targeting (3, 7, 10,
11, 29–34). Future studies should explore the detailed mechanism behind the lack of T
cell modulation following NK cell depletion in vaccinated animals.
Immune suppression by NK cells could serve as an important negative regulatory
mechanism following infection. NK cell dampening of highly functional virus-elicited T
cell responses could be critical to the prevention of immunopathology in unvaccinated
animals by contributing to the inhibition of T cell responses and exhaustion (3, 5, 7, 11).
This was alluded to in our studies by gene expression analysis, where we observed that
CD8 T cells were less enriched for various inhibitory receptors and the T cell exhaus-
tion pathway following NK cell depletion. T cells become progressively exhausted
following LCMV Cl-13 infection, and thus, the exhaustion signature that we observe
may be reﬂective of the early stages of CD8 T cell exhaustion (35, 36). Additionally,
CD8 T cells were less enriched for apoptosis-related pathways in the absence of NK
cells, which may have contributed to their overall survival and higher numbers. The role
of CD4 T cell help for these CD8 T cells remains to be determined (3, 11).
Our ﬁndings for unvaccinated animals are in contrast to our data for vaccinated
animals, where little effect was observed following NK cell depletion. This therefore
suggests that Ad5-GP vaccine-elicited T cells may not require NK rheostat function to
avoid immunopathology. While inhibitory pathways and negative regulation may play
a critical role in preventing immunopathology in a developing primary immune re-
sponse to LCMV Cl-13 (11, 37, 38), vaccine-elicited T cells may employ other regulatory
mechanisms to prevent an overwhelming and detrimental immune response. This is
FIG 6 Legend (Continued)
following NK cell depletion. Networks were generated by using the Cytoscape DyNet plug-in, and interactions were inferred from GeneMania. (C) Expression
of PD-1 on GP33-specﬁc CD8 T cells in unvaccinated animals (n  8 per group). (D) Scaled representation showing the log2 fold changes in gene expression
levels for modules associated with T cell and immune activation at day 8 post-LCMV challenge, comparing vaccinated and unvaccinated animals following NK
cell depletion. All genes shown are signiﬁcant, with a corrected P value cutoff of 0.05.
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concordant with studies that have also suggested that memory T cells are tightly
regulated to prevent immunopathology (39, 40).
In this study, we observed clear NK cell regulation of T cell responses following
LCMV Cl-13 infection in unvaccinated mice. In contrast, we observed that T cell
responses following Ad5-GP immunization alone were largely unregulated by NK cells.
Adenovirus vectors have the ability to stimulate NK cell responses (19, 41–43). However,
we also found that NK cells had little impact on the magnitude of the CD8 T cell
response following immunization (44). The precise mechanisms as to why NK cells have
little to no rheostat function for Ad5-GP vaccine-elicited T cells remain to be deter-
mined. However, it has been suggested that the type of inﬂammatory environment
may play a large role in determining NK cell activities (22).
In conclusion, this study shows that CD4 and CD8 T cells are less susceptible to
NK cell regulation in Ad5-GP-vaccinated animals than in unvaccinated animals. Our data
also demonstrate that Ad5-GP vaccination leads to virus clearance and protection
against NK cell-modulated CD8 T cell-mediated immunopathology, despite high
frequencies of functional T cell responses. While increased levels of functional T cells
contribute to the development of pathology following NK cell depletion, this did not
occur in vaccinated animals. These data suggest that NK cell rheostat activity is
impacted by adenovirus vector vaccination.
MATERIALS AND METHODS
Mice, immunizations, and infections. Female C57BL/6 mice were purchased from Jackson Labo-
ratories (Bar Harbor, ME). Replication-incompetent, recombinant E1/E3-deleted adenovirus serotype 5
(Ad5) vectors were previously constructed (21, 45). Mice were immunized with 1010 viral particles (vp) per
mouse by bilateral intramuscular injection into the hind leg quadriceps. LCMV clone 13 was propagated
as previously described (21). Mice were challenged with 2  106 PFU of LCMV clone 13 via intravenous
(i.v.) injection into the tail vein. For survival studies, body weight was recorded prior to infection. Animals
were euthanized when their weight loss was 20% of their initial weight at the start of infection, which
constitutes humane endpoint criteria. All experiments were performed with approval from the Beth Israel
Deaconess Medical Center (BIDMC) Institutional Animal Care and Use Committee (IACUC).
Sample processing. Blood was collected into 5 mM EDTA–RPMI 1640 medium (Life Technologies/
Corning) to prevent coagulation. Samples were then underlaid with Ficoll-Hypaque (GE Healthcare) for
density centrifugation at 2,200 rpm for 20 min. The interphase was collected into R10 medium, washed
(1,400 rpm for 5 min), and then used for subsequent assays. Tissues were harvested following sacriﬁce and
collected into R10 medium (RPMI, 10% fetal bovine serum [FBS], 2% penicillin-streptomycin). Tissue samples
were ground through 70-m ﬁlters. Spleen samples were treated once with 1 ammonium-chloride-
potassium (ACK) lysis buffer. All samples were washed with R10 medium, passed through a 30-m ﬁlter, and
resuspended in R10 medium.
Cell depletions. Anti-NK1.1 (clone PK136), anti-CD8a (clone 2.43), and the IgG2a isotype control
(clone C1.18.4) were purchased from BioXcell. A total of 500 g of antibody was administered via
intraperitoneal injection on the two subsequent days prior to LCMV infection. NK cell depletions were
90% in blood and liver, 85% in spleen, and 60% in lymph node.
Flow cytometry. Single-cell suspensions were stained for 30 min at 4°C with antibodies against
mouse CD127 (A7R34), KLRG1 (2F1), CD44 (IM7), CD8 (53-6.7), CD4 (RM4-5), PD-1 (RMP1-30), NK1.1
(PK136), CD3 (145-2C11), CD69 (H1.2F3), NKG2D (CX5), and 2B4 (2B4) and near-infrared (IR) live/dead vital
dye (Life Technologies). All antibodies were obtained from BioLegend or BD Biosciences. Major histo-
compatibility complex (MHC) class I tetramer staining was performed with H-2Db tetramers loaded with
the LCMV GP33–41 peptide (KAVYNFATM). Biotinylated monomers were provided by the NIH Tetramer
Core Facility (Emory University, GA). IFN- production was evaluated in response to stimulation by
NP396, GP61, GP33, or GP276 peptides (Anaspec) in the presence of GolgiStop (BD Bioscience) and
GolgiPlug (BD Bioscience). Following incubation at 37°C, samples were stained for surface markers (CD4,
CD8, and CD44 with near-IR live/dead vital dye) and then subsequently stained for 30 min for intracellular
IFN- (XMG1.2). Fixed samples were acquired on an LSR II ﬂow cytometer (BD Biosciences) and analyzed
by using FlowJo 2 v9.9.3 (TreeStar). Unstimulated controls from each individual sample were used for
background subtraction.
Cell sorting and microarray analysis. Isolated splenocytes were enriched for CD8 T cells by using
the EasySep mouse CD8 T cell isolation kit (Stem Cell Technologies). They were subsequently washed
and suspended in magnetically activated cell sorting (MACS) wash buffer (Miltenyi Biotec) and stained
with H-2Db tetramers loaded with the LCMV GP33–41 peptide, CD8, CD44, and vital dye (as described
above). Samples were then washed twice and resuspended in MACS buffer for live-cell sorting on a
FACSAria III instrument (BD Biosciences) to 90% purity. Samples were sorted directly into Qiazol
(Qiagen) and stored at80°C. RNA was extracted by using the RNAdvance tissue isolation kit (Agencourt)
according to the manufacturer’s instructions. Samples were prepared at the Molecular Biology Core
Facility at Dana-Farber Cancer Institute. RNA quality and quantity were evaluated by using the Agilent
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2100 bioanalyzer (Agilent Technologies), prepared by using the 3= IVT Pico kit (Affymetrix), and hybrid-
ized to the mouse genome 430 V2.0 chip (Affymetrix).
Analysis of gene array output data was conducted by using the R statistical language (http://www
.r-project.org/) and the Linear Models for Microarray Data (LIMMA) statistical package from Bioconductor.
Brieﬂy, scanned array images were inspected for artifacts and unusual signal distributions within chips,
and arrays with low overall intensity or variability were removed from the analysis. Raw data were
processed by using the robust multiarray average (RMA) expression measure method in the R Affy
package. The raw intensity values were background corrected, log2 transformed, and then quantile
normalized. Next, a linear model was ﬁt to the normalized data to obtain an expression measure for each
probe set on each array. Analysis of differentially expressed genes was performed by using the LIMMA R
package. The moderated t test implemented in the LIMMA package was used to assess the statistical
signiﬁcance (P  0.05) of the differential expression of genes.
We used GSEA to identify enriched biological pathways between vaccinated and unvaccinated mice
in the presence or absence of NK cells. We used the preranked gene list option of GSEA and tested for
the enrichment of MSigDB-curated gene set C2 and immunologic gene set C7 (http://software
.broadinstitute.org/gsea/msigdb/). For each contrast, we ﬁrst performed differential gene expression
analysis as described above. Next, we ranked all genes by their fold changes (FCs) from the highest FC
to the lowest FC. The ranked list was submitted to GSEA using the preranked option. An enrichment
score (ES) reﬂecting the degree of overrepresentation at the top (or bottom) of the ranked list was
calculated. A gene-based permutation test (1,000 permutations) was used to normalize the ES to correct
for the size of gene sets, assess gene set statistical signiﬁcance (nominal P value), and calculate the
statistical probability of the gene set being a false discovery. We discarded gene sets with an FDR of
25% and a nominal P value of 0.05. Where indicated, enriched gene sets were grouped into modules
reﬂecting the same biological functions. The heat map R function was used to plot the normalized
enrichment score of selected modules from each contrast based on both biological relevance and their
normalized enrichment scores.
Plaque assay. Serum samples were diluted 10-fold in Dulbecco’s modiﬁed Eagle’s medium (DMEM)
(ATCC) with 1% FBS (Sigma) and added to a Vero E6 (ATCC) monolayer in a 6-well plate (Costar; Corning).
Plates were incubated for 1 h at 37°C and rocked every 15 min. Following incubation, a 1:1 mixture
of 1% agarose (Lonza) in 2 medium 199 (Invitrogen) was added on top of the monolayer. After 4
days of incubation at 37°C, a 1:1 mixture of 1% agarose and 2 medium 199 containing a 1:50
dilution of neutral red (Fisher) was added on top of the previous agarose layer. The following day,
plaques were counted.
Histopathology. Tissues were ﬁxed in 10% neutral buffered formalin for 72 h, transferred to 70%
ethanol, and submitted for histopathology processing and hematoxylin and eosin (H&E) staining. Tissue
sections were reviewed independently by two veterinary pathologists and scored for immunopathology
as follows: 1 for minimal, 2 for mild, 3 for moderate, and 4 for severe.
Statistical analyses. Statistical analyses were performed by using GraphPad Prism 6. Data sets were
evaluated with the Mann-Whitney U test or the Mantel-Cox test.
Accession number(s). All microarray data have been deposited in the National Center for Biotech-
nology Information Gene Expression Omnibus database (https://www.ncbi.nlm.nih/gov/geo/) under
accession number GSE107116.
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